Kodiak Sciences (KOD)
(Delayed Data from NSDQ)
$3.28 USD
+0.10 (2.98%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.26 -0.02 (-0.61%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Income Statements
Fiscal Year end for Kodiak Sciences Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 277 | 341 | 267 | 136 | 49 |
Income After Depreciation & Amortization | -277 | -341 | -267 | -136 | -49 |
Non-Operating Income | 17 | 8 | 0 | 3 | 2 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -260 | -334 | -267 | -133 | -47 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -260 | -334 | -267 | -133 | -47 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -260 | -334 | -267 | -133 | -47 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -252 | -331 | -258 | -132 | -49 |
Depreciation & Amortization (Cash Flow) | 25 | 10 | 9 | 4 | 1 |
Income After Depreciation & Amortization | -277 | -341 | -267 | -136 | -49 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 52.41 | 52.25 | 51.79 | 45.74 | 37.85 |
Diluted EPS Before Non-Recurring Items | -4.97 | -6.39 | -5.16 | -2.91 | -1.25 |
Diluted Net EPS (GAAP) | -4.97 | -6.39 | -5.16 | -2.91 | -1.25 |
Fiscal Year end for Kodiak Sciences Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 63.38 | 54.50 | 84.83 | 74.62 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -63.38 | -54.50 | -84.83 | -74.62 |
Non-Operating Income | NA | 3.86 | 4.50 | 4.65 | 3.84 |
Interest Expense | NA | 0.00 | 0.01 | 0.00 | 0.00 |
Pretax Income | NA | -59.52 | -50.01 | -80.19 | -70.78 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -59.52 | -50.01 | -80.19 | -70.78 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -59.52 | -50.01 | -80.19 | -70.78 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 52.48 | 52.46 | 52.38 | 52.34 |
Diluted EPS Before Non-Recurring Items | NA | -1.13 | -0.95 | -1.53 | -1.35 |
Diluted Net EPS (GAAP) | NA | -1.14 | -0.95 | -1.53 | -1.35 |